in this issue
Regions :: Western Europe :: U.K.
Pfizer makes final offer for AstraZeneca, will walk away if offer not accepted
11:13 AM MDT | May 19, 2014 | Natasha Alperowicz
Pfizer said on Sunday that it has raised its offer for AstraZeneca to £69 billion ($116 billion), and said it would walk away if AstraZeneca does not accept the offer. The improved proposal is final and cannot be increased, Pfizer says. AstraZeneca shareholders would receive, for each AstraZeneca share, 1.747 shares in the combined entity and 2,476 pence in cash, representing an indicative value of £55.00. On 2 May, AstraZeneca rejected Pfizer's sweetened proposal. Pfizer says this is an increase of approximately 15% over its 2 May proposal...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee